Dr. Letha Chemmalil
About Dr. Letha Chemmalil
Dr. Letha Chemmalil is the Scientific Associate Director at Bristol-Myers Squibb with over two decades of experience in the pharmaceutical and biopharmaceutical sectors.
Current Role at Bristol-Myers Squibb
Dr. Letha Chemmalil is currently serving as the Scientific Associate Director at Bristol-Myers Squibb in the Greater Boston area. She joined the company in January 2015 and has held multiple roles since then, including Principal Scientist from 2018 to 2020 and Senior Scientist-II from 2015 to 2018. In her current role, she leads a team of Scientists and Senior Scientists, contributing to the company's mission in the pharmaceutical sector.
Past Experience at Amgen
Prior to her current position, Dr. Chemmalil worked at Amgen from 2006 to 2014. At Amgen, she held the titles of Senior Scientist (Process & Product Engineering) from 2010 to 2014 and Scientist from 2006 to 2009. During her eight-year tenure, she contributed to various projects focused on process and product engineering, enhancing the company's innovative capabilities.
Educational Background
Dr. Chemmalil's educational journey is extensive and diverse, covering multiple disciplines. She holds Master's Degrees in Chemical Engineering from Tufts University, MS/MBA from Worcester Polytechnic Institute, and Chemistry from Northeastern University. Additionally, she earned her Bachelor's Degree in Chemistry from the University of Kerala. She further advanced her expertise by obtaining a Doctorate in Engineering & Technology Management from Northcentral University.
Expertise in Analytical Method Development
Dr. Chemmalil has extensive experience in analytical method development and protein characterization. She is proficient with a variety of techniques including HPLC, GC, CE, ICP, Cobas Fara, ELISA, FTIR, CD, FLS, DSC, N-terminal sequencing, amino acid analysis, and mass spectrometry (LC/MS & MALDI TOF MS). Her skills in these areas have been crucial in her roles across multiple companies.
Professional Journey in Pharmaceutical Industry
Dr. Chemmalil has over two decades of experience in the pharmaceutical and biopharmaceutical sectors, starting from 1992. Her career includes roles at several prominent companies. She worked at RepliGen as a Method Development Engineer from 1992 to 1995, at Serono as a Senior Scientist from 1996 to 2000, at Genzyme as a Principal Research Associate in the Mass Spectrometry Group within Structural Protein Chemistry from 2000 to 2002, at Altus Pharmaceuticals as a Scientist & Staff Scientist in Research & Development from 2002 to 2006, and at Amgen in various capacities from 2006 to 2014 before joining Bristol-Myers Squibb.